MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.

Victor H Engelhard Rebecca C ObengKara L CummingsGina R PetroniAngela L AmbakhutwalaKimberly A Chianese-BullockKelly T SmithAmanda LuluNikole VarhegyiMark E SmolkinPaisley MyersKeira E MahoneyJeffrey ShabanowitzNico BuettnerEmily H HallKathleen HadenMark CobboldDonald F HuntGeoffrey WeissElizabeth GaughanCraig L Slingluff

Published in: Journal for immunotherapy of cancer (2021)

NCT01846143.

Keyphrases

clinical trial
phase ii
dendritic cells
cell therapy
open label
study protocol
double blind
skin cancer
phase iii
randomized controlled trial
basal cell carcinoma
immune response